Unlock instant, AI-driven research and patent intelligence for your innovation.

Preparation method of 10-hydroxyl praziquantel and application thereof as anti-schistosomiasis medicine

A technology of hydroxypraziquantel and praziquantel, applied in the field of drug discovery, can solve the problems of poor biological activity and no anti-schistosome activity

Inactive Publication Date: 2012-08-08
SUZHOU UNIV
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The nitroated derivatives showed no anti-schistosome activity, and the aminated derivatives showed poorer biological activity than praziquantel

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation method of 10-hydroxyl praziquantel and application thereof as anti-schistosomiasis medicine
  • Preparation method of 10-hydroxyl praziquantel and application thereof as anti-schistosomiasis medicine
  • Preparation method of 10-hydroxyl praziquantel and application thereof as anti-schistosomiasis medicine

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0029]

[0030] See existing literature reports (Bioorg. Med. Chem. Lett., 2007, 17, 4154-4157), Compound 2 is prepared, specifically comprising:

[0031] Step a: Synthesis of Compound 1

[0032] Praziquantel (3.00 g, 9.60 mmol) was dissolved in sulfuric acid (9.42 g, 5.14 mL, 96 mmol, 10 eq) cooled to 0 °C. Concentrated nitric acid (3.03 g, 2.12 mL, 48 mmol, 5 eq ) was then carefully added. The reaction mixture was stirred at room temperature for 24 hours, cooled with ice, and neutralized with sodium carbonate to pH 8. The reaction mixture was extracted 3 times with EtOAc (150 mL). Combined organic phases with MgSO 4 ), the organic solvent was removed under reduced pressure, and the product was purified by silica gel column (petroleum ether: ethyl acetate 5:1). get the product 1 As a yellow solid 1.34 g, yield 39%. pair compound 1 For analysis, the data is as follows: R F (EtOAc:Pet, 3:1) 0.23; m.p. 88 – 90 ℃; 1 H NMR (200 MHz, CDCl 3 ): 1.44 (m, 10H), 2.47 (...

Embodiment 2

[0037] Embodiment two: In vitro insecticidal activity test of the 10-hydroxypraziquantel obtained in embodiment one

[0038] The mice were infected with the cercariae of Schistosoma japonicum by portal vein infusion, and the juvenile stage (16-18 days after infection) and the adult stage (6 weeks after infection) were collected to collect juvenile and adult worms, and observe the synthesized compound 10-OH by in vitro culture. -PZQ anti-schistosomimesis, adult worms.

[0039] (1) Observe the killing effect of praziquantel derivative 10-OH-PZQ on schistosome larvae: the compound 10-OH-PZQ with a concentration of 1~50 μM has the effect on schistosome larvae. At the same time, as a reference, set the blank control group, praziquantel group, and artesunate group, and then observe the death of schistosome larvae after the action under a light microscope. The results can be found in figure 1 , 2 , 3 and Table 1.

[0040] Figure 1~3 Display: observed under a light microscope, i...

Embodiment 3

[0049] Embodiment 3: The compound 10-OH-PZQ obtained in embodiment 1 in vivo anti-schistosomiasis adult worm test

[0050] Three groups were set up for the experiment, one group was the positive control group for praziquantel, the other group was the compound 10-OH-PZQ group, and the third group was the negative control group (no administration), with 10 mice in each group. Each mouse was infected with 60 cercariae, and on the 28th day after infection, the mice were orally administered with 10-OH-PZQ (200 mg / kg, that is, 200 mg per 1 kg of mouse weight), for 5 consecutive days; The mice in the praziquantel control group were orally administered praziquantel 100 mg / kg for 5 consecutive days; the mice in the three groups were dissected on the 21st day after the administration, the hepatic portal vein was perfused aseptically, and the worms were counted. It was found that the schistosomes in the normal control group did not die (see Figure 5 ), while schistosome death was found...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the field of medicine inventions and relates to a preparation method of a praziquantel derivative and applications of an anti-schistosomiasis medicine. The praziquantel derivative is 10-hydroxyl praziquantel, and the chemical structural formula of the 10-hydroxyl praziquantel is shown as follows: (see the specification). The praziquantel derivative 10-hydroxyl praziquantel is based on the structure of praziquantel, is obtained by hydroxyl derivatization modification on the 10-site of an aromatic ring, and is shown by in-vitro and in-vivo test. The 10-hydroxyl praziquantel can be used as the anti-schistosomiasis medicine, and has the killing function for adolescent worm and adult worm of the schistosomiasis, while the praziquantel only is effective for the adult worm and is basically ineffective for the adolescent worm; and in the compound, the water solubility is better, so that the defect of the praziquantel in the aspect on the druggability can be overcome.

Description

technical field [0001] The invention belongs to the field of drug discovery, and relates to a preparation method of praziquantel derivatives and the application of anti-schistosomiasis drugs. Background technique [0002] Schistosomiasis is a disease caused by humans or mammals infected with schistosomiasis, which seriously endangers human health. Schistosomiasis causes 200 million people to be infected with schistosomiasis every year, 779 million people are at risk of infection, 280,000 people die and the incidence rate exceeds 20 million. Despite the global efforts to control the occurrence of schistosomiasis, schistosomiasis continues to spread to new areas. According to statistics in the early days of the founding of the People's Republic of China, schistosomiasis in my country is distributed in 12 provinces (cities) including Jiangsu, Zhejiang, Shanghai, and Anhui, with a total area of ​​14.8 billion square meters of snails, a total of 11.6 million infected cases, and ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07D471/04A61K31/4985A61P33/12
CPCY02A50/30
Inventor 乔春华夏朝明段文文仇思婕赵越
Owner SUZHOU UNIV